Related Experiment Videos
Essential thrombocythemia and recurrent myocardial infarction
H Kaya1, M Gündogdu, S B Tekin
1Department of Haematology, University of Atatürk, Erzurum, Turkey.
Clinical and Laboratory Haematology
|August 10, 2000
Summary
Recurrent myocardial infarction is rare in essential thrombocythemia (ET). This case highlights a patient with ET experiencing a second myocardial infarction despite controlled thrombocythemia and normal coronary angiography.
Area of Science:
- Cardiology
- Hematology
Background:
- Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
- ET increases the risk of thrombotic events, including myocardial infarction (MI).
Observation:
- A 61-year-old female patient with a history of ET presented with recurrent myocardial infarction.
- Coronary angiography performed 10 days post-infarction revealed normal coronary arteries.
- The patient's ET was reportedly controlled with hydroxyurea treatment.
Findings:
- This case represents only the second reported instance of recurrent myocardial infarction in a patient with essential thrombocythemia.
- The absence of obstructive coronary artery disease despite recurrent MI suggests alternative pathophysiological mechanisms in ET-associated cardiac events.
Implications:
- Further research is needed to elucidate the mechanisms linking ET to recurrent myocardial infarction, especially in the absence of traditional coronary artery disease.
- This case underscores the importance of considering thrombotic etiologies in patients with ET presenting with recurrent cardiac events, even with seemingly normal coronary anatomy.